Pirfenidone for Diabetic Nephropathy - Sharma, Kumar; Ix, Joachim H.; Mathew, Anna V.; Cho, Monique; Pflueger, Axel; Dunn, Stephen R.; Francos, Barbara; Sharma, Shoba; Falkner, Bonita; McGowan, Tracy A.; Donohue, Michael; RamachandraRao, Satish; et al. (Journal of the American Society of Nephrology, 2011)
Keywords: Adult; Aged; Albuminuria - urine; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use; Associated diseases and complications; Biological and medical sciences; Biomarkers - urine; Clinical Research; Creatinine - urine; Diabetes. Impaired glucose tolerance; Diabetic Nephropathies - drug therapy; Diabetic Nephropathies - metabolism; Diabetic Nephropathies - physiopathology; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Female; Fibrosis; Glomerular Filtration Rate - drug effects; Glomerular Filtration Rate - physiology; Humans; Kidney - pathology; Kidneys; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Pyridones - pharmacology; Pyridones - therapeutic use; Treatment Outcome; Urinary system involvement in other diseases. Miscellaneous; Endocrinopathy; Kidney disease; Concomitant disease; Nephrology; Urinary system disease; Diabetes mellitus; Diabetic nephropathy; Pirfenidone; Urology